Implementation of the Generic Drug Labeling Rules 2017

Topics

• Exceptions to compliance with innovator labeling
• Requirements to comply with innovator labeling
• Requirements for generic manufacturers/distributors under the new rule
• New changes to safety information in generic labeling
• Timeline for compliance and what it means within operational activities
• Strategies for implementation of the new rule
• Penalties and/or liabilities for non-compliance

Who should Attend

Attendees from:

• Management of generic companies
• All staff responsible for managing labeling content at generic companies
• Supply chain professionals in the generic companies
• Quality Assurance and Regulatory Affairs professionals from generic companies